Antibiotic-Resistant Enterobacteriaceae
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 6144
Special Issue Editors
Interests: clinical pathology; microbiology; parasitology; micology
Special Issues, Collections and Topics in MDPI journals
Interests: microbiology; molecular microbiology; antimicrobial resistance
Interests: microbiology; molecular microbiology; antimicrobial resistance
Special Issue Information
Dear Colleagues,
The introduction of antimicrobials in the 20th century revolutionized healthcare. Globally, the threat of rising rates of antimicrobial resistance (AMR) is an increasing concern. Enterobacteriaceae, a large family of Gram-negative bacteria including clinically relevant bacterial species, two of which are Escherichia coli and Klebsiella pneumoniae, is showing increasing levels of AMR worldwide. The infection with extended-spectrum β-lactamases (ESBLs) and carbapenemases producing Enterobacteriaceae (CPEs) is associated with increased mortality rates.
Today, 700,000 people die each year as a direct consequence of AMR. It is estimated that by 2050, antimicrobial resistance could cause 10 million deaths annually. Molecular technology methods such as whole-genome sequencing (WGS) provide detailed information on their evolution and possible new strategies.
This Special Issue focuses on antimicrobial resistance in Enterobacteriaceae and will consist of 10–15 manuscripts, which may include original research, review articles, case series, or letters to the editor. We are interested in both qualitative and quantitative research in the following areas:
- Antibiotic resistance and molecular mechanisms;
- Emerging pathogens and active surveillance;
- The development of new antimicrobials;
- Antimicrobial stewardship initiatives and patient outcomes;
- Infection prevention and control programs.
Dr. Jari Intra
Dr. Aurora Piazza
Dr. Davide Carcione
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Enterobacteriaceae
- drug resistance
- antibiotics
- surveillance
- emerging pathogens
- antimicrobial stewardship
